Wenxiao B. Jia

Jinan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Multicenter Cohort Study of Original or Substitute Systemic Therapy With or Without Brain Radiotherapy for Extensive-Stage Small Cell Lung Cancer With Brain-Only Progression After First-Line Treatment.

Multicenter Cohort Study of Original or Substitute Systemic Therapy With or Without Brain Radiotherapy for Extensive-Stage Small Cell Lung Cancer With Brain-Only Progression After First-Line Treatment.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 14, 2026

Reassessing the Incidence and Risk Factors of Radiation Pneumonitis in Treatment-Naive EGFR-Mutant NSCLC With Concurrent Third-Generation EGFR-TKI and Thoracic Radiotherapy.

Reassessing the Incidence and Risk Factors of Radiation Pneumonitis in Treatment-Naive EGFR-Mutant NSCLC With Concurrent Third-Generation EGFR-TKI and Thoracic Radiotherapy.

Journal: International journal of cancer

Published: March 23, 2026

Loss of ADAR1 in lung cancer activates anti-tumour immunity and suppresses tumour cell growth via the RIG-I/MDA5-MAVS pathway.

Loss of ADAR1 in lung cancer activates anti-tumour immunity and suppresses tumour cell growth via the RIG-I/MDA5-MAVS pathway.

Journal: Cancer letters

Published: June 08, 2025

Formation of metal-microplastic complexes in lung adenocarcinoma is associated with increased risk of cancer progression.

Formation of metal-microplastic complexes in lung adenocarcinoma is associated with increased risk of cancer progression.

Journal: Journal of hazardous materials

Published: November 19, 2024

Synergistic enhancement of radio-immunotherapy efficacy by IL-15 via macrophage activation and memory T cell response.

Synergistic enhancement of radio-immunotherapy efficacy by IL-15 via macrophage activation and memory T cell response.

Journal: Cancer letters

Published: September 25, 2024

Irradiated tumor cell-released microparticles enhance the therapeutic efficacy of PD-1 inhibitors by promoting M1-TAMs polarization in NSCLC brain metastases.

Irradiated tumor cell-released microparticles enhance the therapeutic efficacy of PD-1 inhibitors by promoting M1-TAMs polarization in NSCLC brain metastases.

Journal: Cancer letters

Published: May 16, 2024

Role of Surgery in Potentially Resectable Small-Cell Lung Cancer Based on the Eighth Edition of the TNM Classification: A Population Study of the US SEER Database.

Role of Surgery in Potentially Resectable Small-Cell Lung Cancer Based on the Eighth Edition of the TNM Classification: A Population Study of the US SEER Database.

Journal: The clinical respiratory journal

Published: February 29, 2024

Radiation pneumonitis after concurrent aumolertinib and thoracic radiotherapy in EGFR-mutant non-small cell lung cancer patients.

Radiation pneumonitis after concurrent aumolertinib and thoracic radiotherapy in EGFR-mutant non-small cell lung cancer patients.

Journal: BMC cancer

Published: December 05, 2023

Prognostic value of cranial radiotherapy and optimal timing stratified by lung-molGPA for NSCLC patients with brain metastases.

Prognostic value of cranial radiotherapy and optimal timing stratified by lung-molGPA for NSCLC patients with brain metastases.

Journal: Journal of neuro-oncology

Published: July 25, 2023

Clinical features and survival analysis in non-M(3) acute myeloid leukemia patients with ASXL1 gene mutation

Clinical features and survival analysis in non-M(3) acute myeloid leukemia patients with ASXL1 gene mutation

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: January 28, 2023

High post-chemotherapy TIL and increased CD4+TIL are independent prognostic factors of surgically resected NSCLC following neoadjuvant chemotherapy.

High post-chemotherapy TIL and increased CD4+TIL are independent prognostic factors of surgically resected NSCLC following neoadjuvant chemotherapy.

Journal: MedComm

Published: September 14, 2022

Fatal toxicity induced by anti-PD-1 immune checkpoint inhibitor in thymic epithelial tumor.

Fatal toxicity induced by anti-PD-1 immune checkpoint inhibitor in thymic epithelial tumor.

Journal: Immunotherapy

Published: September 12, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026